GlassScriptPhysician profile
Julie E Vanourek
NPI 1053692715
$12,493.18
in general payments reported to CMS, 2019-2025
16 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $59.54 · 2023: $819 · 2024: $271 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $1,929 · Travel and Lodging: $182 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,185.94 |
| Food and Beverage | $1,928.59 |
| Travel and Lodging | $181.80 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11,340.90 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $222.06 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $192.01 | 2022-2025 | Cardiomems, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $147.34 | 2021-2024 | Wainua, Brilinta |
| Cvrx, INC. | $142.27 | 2023-2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $107.28 | 2023-2025 | Opsumit, Uptravi |
| Amgen INC. | $98.84 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.32 | 2023-2024 | Lifevest |
| Scpharmaceuticals INC. | $44.94 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $29.40 | 2024 | |
| Stryker Corporation | $26.61 | 2025 | Artix Mt |
| Janssen Pharmaceuticals, INC | $21.00 | 2024 | Xarelto |
| Corcept Therapeutics | $20.71 | 2025 | Korlym |
| Silk Road Medical, INC. | $17.19 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $14.78 | 2023 | Endurant Iis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.53 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Vanourek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.